Bicycle Therapeutics plc Payments of Debt Issuance Costs
Bicycle Therapeutics plc (BCYC) reported Payments of Debt Issuance Costs of $573.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2023-02-28
- Bicycle Therapeutics plc payments of debt issuance costs for the quarter ending 2020-12-31 was $200.00K.
- Bicycle Therapeutics plc payments of debt issuance costs for fiscal 2020 was $573.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $573.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $373.00K 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |